207 related articles for article (PubMed ID: 34172003)
21. Early deaths in bloodstream infections: a population-based case series.
Kontula KS; Skogberg K; Ollgren J; Järvinen A; Lyytikäinen O
Infect Dis (Lond); 2016; 48(5):379-85. PubMed ID: 26763410
[TBL] [Abstract][Full Text] [Related]
22. Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey.
Trecarichi EM; Giuliano G; Cattaneo C; Ballanti S; Criscuolo M; Candoni A; Marchesi F; Laurino M; Dargenio M; Fanci R; Cefalo M; Delia M; Spolzino A; Maracci L; Nadali G; Busca A; Del Principe MI; Daffini R; Simonetti E; Dragonetti G; Zannier ME; Pagano L; Tumbarello M;
PLoS One; 2019; 14(10):e0224465. PubMed ID: 31661507
[TBL] [Abstract][Full Text] [Related]
23. A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality.
Feldman SF; Temkin E; Wullfhart L; Nutman A; Schechner V; Shitrit P; Shvartz R; Schwaber MJ; Andremont A; Carmeli Y
Clin Microbiol Infect; 2022 Jun; 28(6):879.e1-879.e7. PubMed ID: 34922002
[TBL] [Abstract][Full Text] [Related]
24. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records.
Vihta KD; Stoesser N; Llewelyn MJ; Quan TP; Davies T; Fawcett NJ; Dunn L; Jeffery K; Butler CC; Hayward G; Andersson M; Morgan M; Oakley S; Mason A; Hopkins S; Wyllie DH; Crook DW; Wilcox MH; Johnson AP; Peto TEA; Walker AS
Lancet Infect Dis; 2018 Oct; 18(10):1138-1149. PubMed ID: 30126643
[TBL] [Abstract][Full Text] [Related]
25. Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
de Lastours V; Laouénan C; Royer G; Carbonnelle E; Lepeule R; Esposito-Farèse M; Clermont O; Duval X; Fantin B; Mentré F; Decousser JW; Denamur E; Lefort A
J Antimicrob Chemother; 2020 Aug; 75(8):2334-2343. PubMed ID: 32417924
[TBL] [Abstract][Full Text] [Related]
26. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance.
Berger J; Diab-Elschahawi M; Blacky A; Pernicka E; Spertini V; Assadian O; Koller W; Aichberger KJ
Am J Infect Control; 2010 Dec; 38(10):839-45. PubMed ID: 20650546
[TBL] [Abstract][Full Text] [Related]
27.
Daga AP; Koga VL; Soncini JGM; de Matos CM; Perugini MRE; Pelisson M; Kobayashi RKT; Vespero EC
Front Cell Infect Microbiol; 2019; 9():191. PubMed ID: 31245301
[TBL] [Abstract][Full Text] [Related]
28. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
29. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.
Kang CI; Wi YM; Ko KS; Chung DR; Peck KR; Lee NY; Song JH
Scand J Infect Dis; 2013 Jul; 45(7):519-25. PubMed ID: 23509913
[TBL] [Abstract][Full Text] [Related]
30. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
[TBL] [Abstract][Full Text] [Related]
31. Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.
Lee S; Han SW; Kim KW; Song DY; Kwon KT
Korean J Intern Med; 2014 Jan; 29(1):49-56. PubMed ID: 24574833
[TBL] [Abstract][Full Text] [Related]
32. Nosocomial bloodstream infections in a Finnish tertiary care hospital: a retrospective cohort study of 2175 episodes during the years 1999-2001 and 2005-2010.
Huttunen R; Åttman E; Aittoniemi J; Outinen T; Syrjänen J; Kärki T; Lyytikäinen O
Infect Dis (Lond); 2015 Jan; 47(1):20-6. PubMed ID: 25351869
[TBL] [Abstract][Full Text] [Related]
33. Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.
Bou-Antoun S; Davies J; Guy R; Johnson AP; Sheridan EA; Hope RJ
Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608263
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and risk factors for shock and death from E. coli bacteremia in pediatric hematological patients.
Wang H; Liu J; Huang Z; Tao X; Li J; Hu Y; Dou Q; Zou M; Yan Q; Liu WE
J Infect Dev Ctries; 2019 May; 13(5):365-373. PubMed ID: 32053505
[TBL] [Abstract][Full Text] [Related]
35. [Antibiotic Resistance and Risk Factors for Mortality of Blood Stream Infections (BSIs) with
Zhang WL; Huang J; Wu SY; Liu Y; Long F; Xiao YL; Xie Y; He C; Kang M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):133-135. PubMed ID: 29737104
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections.
Superti SV; Augusti G; Zavascki AP
Rev Inst Med Trop Sao Paulo; 2009; 51(4):211-6. PubMed ID: 19739001
[TBL] [Abstract][Full Text] [Related]
37. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
Zaoutis TE; Goyal M; Chu JH; Coffin SE; Bell LM; Nachamkin I; McGowan KL; Bilker WB; Lautenbach E
Pediatrics; 2005 Apr; 115(4):942-9. PubMed ID: 15805368
[TBL] [Abstract][Full Text] [Related]
39. Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
Harris PNA; Ben Zakour NL; Roberts LW; Wailan AM; Zowawi HM; Tambyah PA; Lye DC; Jureen R; Lee TH; Yin M; Izharuddin E; Looke D; Runnegar N; Rogers B; Bhally H; Crowe A; Schembri MA; Beatson SA; Paterson DL;
J Antimicrob Chemother; 2018 Mar; 73(3):634-642. PubMed ID: 29253152
[TBL] [Abstract][Full Text] [Related]
40. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
